Esmail, Mosrif A.
HRN: 22-74-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
CEFUROXIME 750MG (VIAL)
12/20/2024
12/27/2024
IV
400 Mg
Q 8 Hours
BFC; URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes